GWSG
EDIT icon

GPS Wealth Strategies Group’s Editas Medicine EDIT Stock Holding History

GPS Wealth Strategies Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2
Closed -$3 – 1532
2024
Q4 		$3 Sell
2
-6
-75% -$15 ﹤0.01% 1376
2024
Q3 		$27 Buy
8
+2
+33% +$9 ﹤0.01% 1383
2024
Q2 		$28 Hold
6
– – ﹤0.01% 1349
2024
Q1 		$45 Buy
+6
New +$50 ﹤0.01% 1239

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GPS Wealth Strategies Group's EDIT Position: Q1 2025 in Review

GPS Wealth Strategies Group sold out of Editas Medicine (EDIT) in Q1 2025, closing a stake of 2 shares — an estimated $3 sold.

GPS Wealth Strategies Group first reported a position in EDIT in Q1 2024 and held it in 4 quarters. The position peaked at $45 in Q1 2024. 194 funds tracked by Wall St. Rank hold EDIT as of Q1 2025.

  • GPS Wealth Strategies Group reported no remaining Editas Medicine position as of Q1 2025 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 2 Editas Medicine shares in Q1 2025, an estimated $3.
  • GPS Wealth Strategies Group first reported a position in Editas Medicine in Q1 2024 and held it in 4 quarters.
  • GPS Wealth Strategies Group's Editas Medicine position peaked at $45 in Q1 2024.
  • 194 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q1 2025, filed 15 Apr 2025.